Artículos -

tacrolimus

"Biological relevance of Hsp90-binding immunophilins in cancer development and treatment" (2016) Mazaira, G.I.;Camisay, M.F.;De Leo, S. (...)Galigniana, M.D. International Journal of Cancer. 138(4):797-808

"Molecular chaperone activity and biological regulatory actions of the TPR-domain immunophilins FKBP51 and FKBP52" (2014) Erlejman, A.G.;Lagadari, M.;Harris, D.C. (...)Galigniana, M.D. Current Protein and Peptide Science. 15(3):205-215

"Molecular basis of mineralocorticoid receptor action in the nervous system" (2013) Molinari, A.M.;Machado-Rada, M.Y.;Mazaira, G.I. (...)Galigniana, M.D. CNS and Neurological Disorders - Drug Targets. 12(8):1163-1174

"Hsp90-binding immunophilins as a potential new platform for drug treatment" (2013) Erlejman, A.G.; Lagadari, M.; Galigniana, M.D. Future Medicinal Chemistry. 5(5):591-607

"New antibacterials for the treatment of toxoplasmosis; A patent review" (2012) Rodriguez, J.B.; Szajnman, S.H. Expert Opinion on Therapeutic Patents. 22(3):311-333

"Regulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52)" (2011) Sivils, J.C.; Storer, C.L.; Galigniana, M.D.; Cox, M.B. Current Opinion in Pharmacology. 11(4):314-319

"Nuclear factor (NF)-κB controls expression of the immunoregulatory glycan-binding protein galectin-1" (2011) Toscano, M.A.;Campagna, L.;Molinero, L.L. (...)Rabinovich, G.A. Molecular Immunology. 48(15-16):1940-1949

"FKBP51 and FKBP52 in signaling and disease" (2011) Storer, C.L.;Dickey, C.A.;Galigniana, M.D. (...)Cox, M.B. Trends in Endocrinology and Metabolism. 22(12):481-490

"Molecular mechanisms of action of some immunosuppresive drugs " (2008) Liberman, A.C.; Druker, J.; Refojo, D.; Arzt, E. Medicina. 68(6):455-464